Medical economics

Pfizer to buy Array BioPharma in deal worth $11.4 billion

Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring.

Medications

Lilly selling half-price version of popular Humalog insulin

A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices.

Pediatrics

The poorest pupils spurn school meals, study finds

Pupils from the poorest backgrounds are the ones most likely to leave school at lunchtime to buy food, a University of Hertfordshire investigation revealed today—and the choice is often chips together with other items high ...

page 27 from 40